Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
NewsWHO and the ADVANCE-ID Network co-hosted a clinical trial workshop in Singapore, drawing 77 researchers from Africa, Asia, and Europe. The 2.5-day event translated WHO best-practice guidance into hands-on learning, tackling real-world trial design challenges — especially in low- and middle-income countries. It's part of a broader push to build stronger, more equitable clinical trial ecosystems worldwide.
The World Health Organization (WHO) and the ADVANCE-ID Network held their Clinical Trial Workshop 2026 in Singapore (August 31–September 2), bringing together researchers from Africa, Asia, and Europe to sharpen skills in designing and running high-quality clinical trials. The event was organized under the Global Clinical Trials Forum (GCTF) and served as a bridge between WHO's published best-practice guidance and real-world application.
Participants worked in mentored groups with clinical trial specialists, statisticians, and public engagement experts to develop and pitch research proposals. Discussions also tackled persistent barriers in low- and middle-income countries (LMICs), including regulatory hurdles, limited research infrastructure, and equity gaps.
By the Numbers:
Why it matters: Strengthening clinical trial capacity — especially in LMICs — is critical for generating locally relevant evidence and ensuring global health research is more inclusive and equitable. This workshop is a concrete step toward that goal.
